Target Healthcare REIT (LON:THRL – Get Free Report)’s share price reached a new 52-week high on Monday . The stock traded as high as GBX 114.80 and last traded at GBX 114.60, with a volume of 18884 shares trading hands. The stock had previously closed at GBX 114.20.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price target on shares of Target Healthcare REIT in a report on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of GBX 101.
View Our Latest Report on Target Healthcare REIT
Target Healthcare REIT Stock Up 0.0%
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Featured Stories
- Five stocks we like better than Target Healthcare REIT
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
